임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 중· Colitis, UlcerativeA Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
리드: 화이자
- 2상모집 중· OverweightA Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
리드: 화이자
- 2상모집 중· Prostate Cancer (Adenocarcinoma)A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate
협력: 화이자
- 2상모집 중· Muscle-invasive Bladder CancerA Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
협력: 화이자
- 2상모집 중· Multiple MyelomaA Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
협력: 화이자
- 2상모집 중· Metastatic Breast Cancer ( HER2 Negative)Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
협력: 화이자
- 2상모집 중· Metastatic Renal Cell CarcinomaA Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
협력: 화이자
- 2상모집 중· Atopic DermatitisA Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
리드: 화이자
- 2상모집 중· Chronic Spontaneous UrticariaA Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
리드: 화이자
- 2상모집 중· Multiple Myeloma, Newly DiagnosedFrontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
협력: 화이자
- 2상모집 중· Refractory Multiple MyelomaOutpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma
협력: 화이자
- 2상모집 중· Waldenstrom MacroglobulinemiaEfficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia
협력: 애브비, 화이자
- 2상모집 중· Multiple MyelomaSelf-administration of Subcutaneous Elranatamab in the Patients' Homes.
협력: 화이자
- 2상모집 중· Acute Lymphoblastic LeukemiaTherapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
협력: 암젠, 화이자
- 2상모집 중· Multiple MyelomaMeasurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
협력: 화이자
- 2상모집 중· Gram-negative Bacterial InfectionA Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
리드: 화이자 · 협력: 애브비
- 2상모집 중· Prostate AdenocarcinomaEffects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
협력: 화이자
- 2상모집 중· Smoldering Multiple MyelomaUse of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
협력: 화이자
- 2상모집 중· Diffuse Cutaneous Systemic SclerosisOpen Label Extension Study of Brentuximab Vedotin in Early dcSSc
협력: 화이자
- 2상모집 중· ACUTE LYMPHOBLASTIC LEUKEMIAA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
리드: 화이자
- 2상모집 중· Ovarian CancerZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
협력: 화이자
- 2상모집 중· Metastatic Renal Cell CarcinomaAxitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients
협력: 화이자
- 2상모집 중· Gram-negative Bacterial InfectionsStudy of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
리드: 화이자
- 2상모집 중· Ulcerative ColitisA Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
리드: 화이자
- 2상모집 중· Hodgkin LymphomaPembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
협력: 머크(MSD), 화이자
- 2상모집 중· Urothelial CarcinomaA Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
리드: 화이자 · 협력: 머크(MSD)
- 2상모집 중· Primary Immune ThrombocytopeniaSafety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
리드: 화이자
- 2상모집 중· Breast CancerAvelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
협력: 화이자
- 2상모집 중· Urothelial CarcinomaTALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma
협력: 화이자
- 2상모집 중· Locally Advanced or Metastatic ER+ HER2- Breast CancerStudy of PF-07248144 in Advanced or Metastatic Solid Tumors
리드: 화이자
- 2상모집 중· Acute Myeloid LeukemiaFractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia
협력: 화이자
- 2상모집 중· Lymphoma, Non-HodgkinCanadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
협력: 아스트라제네카, BMS, 화이자, 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.